These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9730898)

  • 1. Qa-1b binds conserved class I leader peptides derived from several mammalian species.
    Kurepa Z; Hasemann CA; Forman J
    J Exp Med; 1998 Sep; 188(5):973-8. PubMed ID: 9730898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the murine CD94-NKG2A receptor in complex with Qa-1
    MacLachlan BJ; Sullivan LC; Brooks AG; Rossjohn J; Vivian JP
    FEBS J; 2024 Apr; 291(7):1530-1544. PubMed ID: 38158698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A peptide from heat shock protein 60 is the dominant peptide bound to Qa-1 in the absence of the MHC class Ia leader sequence peptide Qdm.
    Davies A; Kalb S; Liang B; Aldrich CJ; Lemonnier FA; Jiang H; Cotter R; Soloski MJ
    J Immunol; 2003 May; 170(10):5027-33. PubMed ID: 12734347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nonclassical MHC class I molecule Qa-1 forms unstable peptide complexes.
    Kambayashi T; Kraft-Leavy JR; Dauner JG; Sullivan BA; Laur O; Jensen PE
    J Immunol; 2004 Feb; 172(3):1661-9. PubMed ID: 14734748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential requirement for tapasin in the presentation of leader- and insulin-derived peptide antigens to Qa-1b-restricted CTLs.
    Li L; Sullivan BA; Aldrich CJ; Soloski MJ; Forman J; Grandea AG; Jensen PE; Van Kaer L
    J Immunol; 2004 Sep; 173(6):3707-15. PubMed ID: 15356116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of HLA-E peptide-binding specificity and contact residues in bound peptide required for recognition by CD94/NKG2.
    Miller JD; Weber DA; Ibegbu C; Pohl J; Altman JD; Jensen PE
    J Immunol; 2003 Aug; 171(3):1369-75. PubMed ID: 12874227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A structural basis for antigen presentation by the MHC class Ib molecule, Qa-1b.
    Zeng L; Sullivan LC; Vivian JP; Walpole NG; Harpur CM; Rossjohn J; Clements CS; Brooks AG
    J Immunol; 2012 Jan; 188(1):302-10. PubMed ID: 22131332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9.
    Braud V; Jones EY; McMichael A
    Eur J Immunol; 1997 May; 27(5):1164-9. PubMed ID: 9174606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative ability of Qdm/Qa-1b, kb, and Db to protect class Ilow cells from NK-mediated lysis in vivo.
    Jia SH; Kurepa Z; Bai A; Forman J
    J Immunol; 2000 Dec; 165(11):6142-7. PubMed ID: 11086047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dominance of a single peptide bound to the class I(B) molecule, Qa-1b.
    DeCloux A; Woods AS; Cotter RJ; Soloski MJ; Forman J
    J Immunol; 1997 Mar; 158(5):2183-91. PubMed ID: 9036964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Qa-1(b) peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes.
    Kraft JR; Vance RE; Pohl J; Martin AM; Raulet DH; Jensen PE
    J Exp Med; 2000 Sep; 192(5):613-24. PubMed ID: 10974028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells.
    Brooks AG; Borrego F; Posch PE; Patamawenu A; Scorzelli CJ; Ulbrecht M; Weiss EH; Coligan JE
    J Immunol; 1999 Jan; 162(1):305-13. PubMed ID: 9886400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide binding to the class Ib molecule, Qa-1b.
    Kurepa Z; Forman J
    J Immunol; 1997 Apr; 158(7):3244-51. PubMed ID: 9120280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qa-1 interaction and T cell recognition of the Qa-1 determinant modifier peptide.
    Cotterill LA; Stauss HJ; Millrain MM; Pappin DJ; Rahman D; Canas B; Chandler P; Stackpoole A; Simpson E; Robinson PJ; Dyson PJ
    Eur J Immunol; 1997 Sep; 27(9):2123-32. PubMed ID: 9341749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of Qa-1a with bound Qa-1 determinant modifier peptide.
    Ying G; Wang J; Kumar V; Zajonc DM
    PLoS One; 2017; 12(8):e0182296. PubMed ID: 28767728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis.
    Borrego F; Ulbrecht M; Weiss EH; Coligan JE; Brooks AG
    J Exp Med; 1998 Mar; 187(5):813-8. PubMed ID: 9480992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Single-Domain TCR-like Antibody Selective for the Qa-1
    Ghaffari S; Upchurch-Ange K; Gimlin S; Tripathi T; Sluijter M; Middelburg J; van Hall T; Weidanz J
    J Immunol; 2022 May; 208(9):2246-2255. PubMed ID: 35418467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of the molecular factors controlling Qa1-mediated protection of target cells from NK lysis.
    Gays F; Fraser KP; Toomey JA; Diamond AG; Millrain MM; Dyson PJ; Brooks CG
    J Immunol; 2001 Feb; 166(3):1601-10. PubMed ID: 11160201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E.
    Valés-Gómez M; Reyburn HT; Erskine RA; López-Botet M; Strominger JL
    EMBO J; 1999 Aug; 18(15):4250-60. PubMed ID: 10428963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cell surveillance of intracellular antigen processing pathways mediated by recognition of HLA-E and Qa-1b by CD94/NKG2 receptors.
    O'Callaghan CA
    Microbes Infect; 2000 Apr; 2(4):371-80. PubMed ID: 10817639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.